Yufeng Guo

Beijing, 100102, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Dual-modal stimuli-responsive inherently chiral AIEgens: tunable circularly polarized luminescence and information encryption.

Dual-modal stimuli-responsive inherently chiral AIEgens: tunable circularly polarized luminescence and information encryption.

Journal: Chemical communications (Cambridge, England)
Published: September 03, 2026

Erratum: Author correction to "AI-integrated IQPD framework of quality prediction and diagnostics in small-sample multi-unit pharmaceutical manufacturing: advancing from experience-driven to data-driven manufacturing" [Acta Pharm Sin B 15 (2025) 4193-4209].

Erratum: Author correction to "AI-integrated IQPD framework of quality prediction and diagnostics in small-sample multi-unit pharmaceutical manufacturing: advancing from experience-driven to data-driven manufacturing" [Acta Pharm Sin B 15 (2025) 4193-4209].

Journal: Acta pharmaceutica Sinica. B
Published: January 01, 2026

Restoring the potency of a neutralizing antibody via guided hypermutation with hyper-antibody editor HAE1.

Restoring the potency of a neutralizing antibody via guided hypermutation with hyper-antibody editor HAE1.

Journal: Genome research
Published: September 07, 2025

Engineering Rhodotorula toruloides as a platform organism for de novo synthesis of fatty-acid esters.

Engineering Rhodotorula toruloides as a platform organism for de novo synthesis of fatty-acid esters.

Journal: Nature communications
Published: June 30, 2025

Targeting tumor-intrinsic S100 calcium-binding protein A1 augments antitumor immunity and potentiates immunotherapy efficacy.

Targeting tumor-intrinsic S100 calcium-binding protein A1 augments antitumor immunity and potentiates immunotherapy efficacy.

Journal: Signal transduction and targeted therapy
Published: September 06, 2024

ATAD2 is a potential immunotherapy target for patients with small cell lung cancer harboring HLA-A∗0201.

ATAD2 is a potential immunotherapy target for patients with small cell lung cancer harboring HLA-A∗0201.

Journal: EBioMedicine
Published: August 06, 2024

Fork coupling directs DNA replication elongation and termination.

Fork coupling directs DNA replication elongation and termination.

Journal: Science (New York, N.Y.)
Published: March 14, 2024

Deciphering the predictive value of senescence-related signature in lung adenocarcinoma: Implications for antitumor immunity and immunotherapy efficacy.

Deciphering the predictive value of senescence-related signature in lung adenocarcinoma: Implications for antitumor immunity and immunotherapy efficacy.

Journal: Heliyon
Published: February 12, 2024

Discovery of a novel ROS-based signature for predicting prognosis and immunosuppressive tumor microenvironment in lung adenocarcinoma.

Discovery of a novel ROS-based signature for predicting prognosis and immunosuppressive tumor microenvironment in lung adenocarcinoma.

Journal: Journal of Cancer
Published: January 06, 2024

Comparative proteomic profiling of plasma exosomes in lung cancer cases of liver and brain metastasis.

Comparative proteomic profiling of plasma exosomes in lung cancer cases of liver and brain metastasis.

Journal: Cell & bioscience
Published: October 17, 2022

Cohesin maintains replication timing to suppress DNA damage on cancer genes.

Cohesin maintains replication timing to suppress DNA damage on cancer genes.

Journal: Nature genetics
Published: September 29, 2022

WITHDRAWN: Proteomic analysis of plasma-derived exosomes identifies biomarkers that distinguish brain and liver metastasis in lung cancer patients.

WITHDRAWN: Proteomic analysis of plasma-derived exosomes identifies biomarkers that distinguish brain and liver metastasis in lung cancer patients.

Journal: Cancer letters
Published: May 19, 2022
Showing 1-12 of 16

Last Updated: 09/26/2026